Suppr超能文献

非酒精性脂肪性肝病与甲状腺功能减退:你需要了解的内容。

Nonalcoholic Fatty Liver Disease and Hypothyroidism: What You Need to Know.

作者信息

Bikeyeva Viktoriya, Abdullah Ahmed, Radivojevic Aleksandra, Abu Jad Anas A, Ravanavena Anvesh, Ravindra Chetna, Igweonu-Nwakile Emmanuelar O, Ali Safina, Paul Salomi, Yakkali Shreyas, Teresa Selvin Sneha, Thomas Sonu, Hamid Pousette

机构信息

Internal Medicine, California Institute of Behavioral Neurosciences & Psychology, Fairfield, USA.

Behavioral Neurosciences and Psychology, California Institute of Behavioral Neurosciences & Psychology, Fairfield, USA.

出版信息

Cureus. 2022 Aug 16;14(8):e28052. doi: 10.7759/cureus.28052. eCollection 2022 Aug.

Abstract

Non-alcoholic fatty liver disease (NAFLD) represents one of the leading causes of chronic liver disease globally, perhaps because of the drastic increase in prevalence around the world during the last 20 years and continues growing. The disease starts from simple steatosis (NAFL) that can progress to non-alcoholic steatohepatitis (NASH) and, in some patients, progress to cirrhosis and hepatocellular carcinoma (HCC). The pathogenesis and pathophysiology of NAFLD are complex and involve different factors (genetic, metabolic, endocrinopathies, and others). One of the concerns that appeared in recent years is hypothyroidism-induced NAFLD. The pathogenesis is compound and not well understood, and an association between hypothyroidism and NAFLD remains controversial because of insufficient studies that can confirm it. More research is needed to determine the association between hypothyroidism and NAFLD and the underlying mechanisms. In this review, we will discuss a more in-depth analysis of the physiology of thyroid hormones (TH) as well as the pathophysiology of hypothyroidism-induced NAFLD and, based on the recent meta-analyses, the association of thyroid hormones and NAFLD.

摘要

非酒精性脂肪性肝病(NAFLD)是全球慢性肝病的主要病因之一,这可能是由于在过去20年中全球患病率急剧上升且仍在持续增长。该疾病始于单纯性脂肪变性(NAFL),可进展为非酒精性脂肪性肝炎(NASH),在某些患者中,还会进展为肝硬化和肝细胞癌(HCC)。NAFLD的发病机制和病理生理学很复杂,涉及不同因素(遗传、代谢、内分泌疾病等)。近年来出现的一个问题是甲状腺功能减退症诱发的NAFLD。其发病机制复杂且尚未完全明确,由于缺乏足够的研究来证实,甲状腺功能减退症与NAFLD之间的关联仍存在争议。需要更多研究来确定甲状腺功能减退症与NAFLD之间的关联及其潜在机制。在本综述中,我们将更深入地分析甲状腺激素(TH)的生理学以及甲状腺功能减退症诱发NAFLD的病理生理学,并基于近期的荟萃分析,探讨甲状腺激素与NAFLD的关联。

相似文献

1
Nonalcoholic Fatty Liver Disease and Hypothyroidism: What You Need to Know.
Cureus. 2022 Aug 16;14(8):e28052. doi: 10.7759/cureus.28052. eCollection 2022 Aug.
2
Pathogenesis of hypothyroidism-induced NAFLD: Evidence for a distinct disease entity?
Dig Liver Dis. 2019 Apr;51(4):462-470. doi: 10.1016/j.dld.2018.12.014. Epub 2019 Jan 2.
3
Association of non-alcoholic fatty liver disease with thyroid function: A systematic review and meta-analysis.
Dig Liver Dis. 2018 Nov;50(11):1153-1162. doi: 10.1016/j.dld.2018.08.012. Epub 2018 Aug 23.
5
Hepatic transcriptome signatures in patients with varying degrees of nonalcoholic fatty liver disease compared with healthy normal-weight individuals.
Am J Physiol Gastrointest Liver Physiol. 2019 Apr 1;316(4):G462-G472. doi: 10.1152/ajpgi.00358.2018. Epub 2019 Jan 17.
6
Non-alcoholic fatty liver disease and thyroid dysfunction: a systematic review.
World J Gastroenterol. 2014 Jul 7;20(25):8102-9. doi: 10.3748/wjg.v20.i25.8102.
7
Hypothyroidism and nonalcoholic fatty liver disease - a chance association?
Horm Mol Biol Clin Investig. 2018 Oct 26;41(1):/j/hmbci.2020.41.issue-1/hmbci-2018-0047/hmbci-2018-0047.xml. doi: 10.1515/hmbci-2018-0047.
8
Non-alcoholic Fatty Liver Disease in Overt Hypothyroidism: A Cross-Sectional Study in a Tertiary Care Hospital.
Cureus. 2023 Apr 4;15(4):e37094. doi: 10.7759/cureus.37094. eCollection 2023 Apr.
9
Histopathology of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis.
World J Gastroenterol. 2014 Nov 14;20(42):15539-48. doi: 10.3748/wjg.v20.i42.15539.
10
Clinical epidemiology and disease burden of nonalcoholic fatty liver disease.
World J Gastroenterol. 2017 Dec 21;23(47):8263-8276. doi: 10.3748/wjg.v23.i47.8263.

引用本文的文献

4
Thyroid hormone and the Liver.
Hepatol Commun. 2024 Dec 20;9(1). doi: 10.1097/HC9.0000000000000596. eCollection 2025 Jan 1.
8
Low thyroid function is associated with metabolic dysfunction-associated steatotic liver disease.
JGH Open. 2024 Feb 23;8(2):e13038. doi: 10.1002/jgh3.13038. eCollection 2024 Feb.

本文引用的文献

1
Nonalcoholic Fatty Liver Disease and Endocrine Axes-A Scoping Review.
Metabolites. 2022 Mar 29;12(4):298. doi: 10.3390/metabo12040298.
2
Sensitivity to Thyroid Hormone Indices Are Closely Associated With NAFLD.
Front Endocrinol (Lausanne). 2021 Nov 5;12:766419. doi: 10.3389/fendo.2021.766419. eCollection 2021.
3
Non-alcoholic Steatohepatitis Pathogenesis, Diagnosis, and Treatment.
Front Cardiovasc Med. 2021 Sep 7;8:742382. doi: 10.3389/fcvm.2021.742382. eCollection 2021.
4
Non-Alcoholic Fatty Liver Disease: Metabolic, Genetic, Epigenetic and Environmental Risk Factors.
Int J Environ Res Public Health. 2021 May 14;18(10):5227. doi: 10.3390/ijerph18105227.
5
The relationship between non-alcoholic fatty liver disease and hypothyroidism: A systematic review and meta-analysis.
Medicine (Baltimore). 2021 Apr 30;100(17):e25738. doi: 10.1097/MD.0000000000025738.
6
Diagnosis and management of secondary causes of steatohepatitis.
J Hepatol. 2021 Jun;74(6):1455-1471. doi: 10.1016/j.jhep.2021.01.045. Epub 2021 Feb 10.
7
Nonalcoholic fatty liver disease as a metabolic disease in humans: A literature review.
Diabetes Obes Metab. 2021 May;23(5):1069-1083. doi: 10.1111/dom.14322. Epub 2021 Feb 10.
8
Pathophysiology of NASH in endocrine diseases.
Endocr Connect. 2021 Feb;10(2):R52-R65. doi: 10.1530/EC-20-0490.
10
Mutual interaction between endoplasmic reticulum and mitochondria in nonalcoholic fatty liver disease.
Lipids Health Dis. 2020 Apr 13;19(1):72. doi: 10.1186/s12944-020-01210-0.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验